Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Legendre

Showing results (21-30 of 309) with videos related to

Pageof 31
Sort By:
Nephrologie|January 1, 1994
[Viral hepatitis in hemodialysis and renal transplantation patients]S Pol, C Legendre
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1994
[Hydroxyethylstarch and osmotic nephrosis]C Legendre, A Atinault
Advances in Nephrology From the Necker Hospital|January 1, 1996
Chronic rejection: is allograft destruction an inevitable phenomenon?H Kreis, C Legendre
Nephrologie & Therapeutique|September 26, 2008
[Interest of screening biopsies in renal transplantation]L-H Noël, C Legendre
Acta Haematologica|January 1, 1979
Amydopyrine pancytopenia: detection of leucocytotoxic antibodies by a 51Cr-release testM Jeannet, D Lew, C Legendre
Nephrologie|January 31, 2002
[Pharmacology of mycophenolate mofetil: recent data and clinical consequences]E Thervet, D Anglicheau, C Legendre
Diabetes & Metabolism|May 17, 2001
[New immunosuppressive drugs and diabetes]C Legendre, E Thervet, J Bédrossian
Hepato-Gastroenterology|August 1, 1989
Dysplasia and cancer in ulcerative colitisB Desaint, C Legendre, C Florent
Soins. Cardiologie|April 1, 1984
[Life of cardiac children]A Casasoprana, C Legendre, J Laville
The New England Journal of Medicine|August 15, 1996
Long-term outcome of hepatitis C infection after liver transplantationS Pol, V Garrigue, C Legendre
Pageof 31

Showing results (21-30 of 309) with videos related to

Sort By:
Pageof 31
Nephrologie|January 1, 1994
[Viral hepatitis in hemodialysis and renal transplantation patients]S Pol, C Legendre
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1994
[Hydroxyethylstarch and osmotic nephrosis]C Legendre, A Atinault
Advances in Nephrology From the Necker Hospital|January 1, 1996
Chronic rejection: is allograft destruction an inevitable phenomenon?H Kreis, C Legendre
Nephrologie & Therapeutique|September 26, 2008
[Interest of screening biopsies in renal transplantation]L-H Noël, C Legendre
Acta Haematologica|January 1, 1979
Amydopyrine pancytopenia: detection of leucocytotoxic antibodies by a 51Cr-release testM Jeannet, D Lew, C Legendre
Nephrologie|January 31, 2002
[Pharmacology of mycophenolate mofetil: recent data and clinical consequences]E Thervet, D Anglicheau, C Legendre
Diabetes & Metabolism|May 17, 2001
[New immunosuppressive drugs and diabetes]C Legendre, E Thervet, J Bédrossian
Hepato-Gastroenterology|August 1, 1989
Dysplasia and cancer in ulcerative colitisB Desaint, C Legendre, C Florent
Soins. Cardiologie|April 1, 1984
[Life of cardiac children]A Casasoprana, C Legendre, J Laville
The New England Journal of Medicine|August 15, 1996
Long-term outcome of hepatitis C infection after liver transplantationS Pol, V Garrigue, C Legendre
Pageof 31